Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Percutaneous transhepatic biliary stenting with conventional linear ^125^I seeds strand
The First People's Hospital of Lianyungang
Malignant Obstructive Jaundice
1 trial -
Pharmacogenomic Testing with the "Global Diversity Array with Enhanced PGx"
Atrium Therapeutics
Cancer
1 trial -
Phase 1 Wonderlab Product
Chongqing Precision Biotech Co., Ltd
Diabetes
1 trial -
Phentermine
Takeda
Obesity
1 trial -
Phytosterols & placebo
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-alcoholic Fatty Liver Disease
1 trial -
Ping On Ointment
The University of Hong Kong
Temporomandibular Disorders
1 trial -
Pitavastatin and placebo
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Dyslipidemia
1 trial -
Placebo
BRIGHT MINDS BIOSCIENCES INC.
Chronic Pain
1 trial -
Placebo
Hospital Authority, Hong Kong
Hypertension in Pregnancy
1 trial -
Placebo
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
2 trials -
Placebo
BRIGHT MINDS BIOSCIENCES INC.
Magnetic Resonance Imaging
1 trial -
Placebo
KYOWA KIRIN AUSTRALIA PTY LTD
Healthy
1 trial -
Placebo
United Therapeutics Europe Ltd
Healthy
1 trial -
Placebo
BRIGHT MINDS BIOSCIENCES INC.
Cocaine-Related Disorder
1 trial -
Placebo
United Therapeutics Europe Ltd
Chronic Kidney Failure
1 trial -
Placebo
Regeneron Ireland Designated Activity Company (DAC)
Knee Osteoarthritis
1 trial -
Placebo
Hospital Authority, Hong Kong
Chronic Kidney Disease
1 trial -
Placebo (for Motilitone)
Samsung Bioepis NL B.V.
Dyspepsia
1 trial -
Placebo 1 to Probiotic A
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastrointestinal Dysfunction
1 trial -
Placebo and Escitalopram
Takeda
Panic Disorder
1 trial -
Placebo plus high-intensity statin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Coronary Syndrome
1 trial -
Power Line Program
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Metabolic Health
1 trial -
Prebiotic Fiber Supplement + loperamide hydrochloride capsule
The First People's Hospital of Lianyungang
Chemotherapy-related Diarrhea
1 trial -
Prebiotics
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ulcerative Colitis
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources